Pfizer On Monday it said that it might end the event of its experimental every ...
Amgen On Wednesday, there have been two critical studies within the late stage for his ...
The booming marketplace for weight reduction medicines has won a brand new potential competitor. Abbvie ...
By Tom Murphy, AP Health Writer Deliveries of obese treatments with high demand improveBut that ...
Shares of Hims & Hers Health 22% closed on Tuesday, the day after the Telemealth ...
Hims & Hers Health The stocks rose by 18% on Monday by prolonged trade after ...
Dan Skovronsky knows what makes good obesity drugs. As a Chief Scientific Officer Eli LillyHe ...
Eli Lilly reported on Thursday Mixed results For the fourth quarter, also because the demand ...
Just a few years ago, a little-known drug called Ozempic – previously used only to ...
When Virta Health founder and CEO Sami Inkinen approached employers a number of years ago ...